Penn Medicine Provider
Dermatology
Emily Lynde Baumrin, MD, MSCE
she/her
4.9
(223)
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Perelman
Schedule onlineCall 215-662-2737

About me

  • Director, Graft-versus-host Disease Subspecialty Clinic, Department of Dermatology
  • Assistant Professor of Dermatology at the Hospital of the University of Pennsylvania
  • Assistant Professor of Dermatology in Medicine (Hematology-Oncology)

Dr. Emily Baumrin is a dermatologist and internal medicine physician who treats patients with dermatologic diseases. Her research aims to improve the lives of patients suffering from dermatologic complications of transplantation and cancer therapies, including graft-versus-host disease (GVHD). She leads a research program that focuses on understanding skin GVHD, and the best ways to prevent, diagnose and treat this condition. She serves as director of Penn Dermatology’s Graft-versus-host Disease Multi-disciplinary Clinic. 

Education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: Massachusetts General Hospital/Brigham and Women’s Hospital

What my patients think about me

Average Rating
4.9

223 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

June 2025
5.0
5.0
everything went well.
May 2025
5.0
5.0
fast and efficient
May 2025
5.0
5.0
she was on time helpful answered questions
May 2025
5.0
5.0
she was highly caring and knowledgeable.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Baumrin is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Baumrin E, Pidala JA, Mitchell S, Onstad L, Lee SJ. Development of the Lee Symptom Scale-Skin Sclerosis for chronic GVHD-associated sclerosis , Blood: 2025

Baumrin E, Cronholm PF, Kearney MD, Mengesha M, Cesar LG, Keddem S, Schapira MM, Lee SJ, Loren AW, Gelfand JM. Outcomes of Importance to Patients Living With Cutaneous Chronic Graft-vs-Host Disease , JAMA Dermatol: 2025

Alvarado SM, Cohen OG, Lattanzio K, Haun P, Gelfand JM, Loren AW, Chung J, Baumrin E. Histopathologic Analysis of Chronic Cutaneous Graft-Versus-Host Disease , Am J Dermatopathol: 2024

Pidala JA, Onstad L, Baumrin E, Carpenter PA, Cutler CS, Arai S, Kitko CL, Chen GL, Lee SJ. Comparison of treatment response measures in cutaneous sclerosis after allogeneic hematopoietic cell transplantation , Blood Adv: 2024

Choe J, Shields A, Ferreira A, Gold S, Gotschall JW, Kamal K, Rios A, Wang RH, Baumrin E, Dommasch ED, Yeung H, Lipoff JB, Barbieri JS. Isotretinoin for Acne in Transgender and Gender-Diverse Individuals Receiving Masculinizing Hormone Therapy , JAMA Dermatol: 2024

Baumrin E, Shin DB, Mitra N, Pidala J, El Jurdi N, Lee SJ, Loren AW, Gelfand JM. Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease , JAMA Dermatol, 160(4): 2024,393-401

Rastogi S, Kim EJ, Gelfand JM, Loren AW, Baumrin E. Chronic Graft-versus-Host Disease-Associated Muscle Cramps: Severity and Response to Immunomodulatory Therapies , Transplant Cell Ther, 30(3): 2024,338

Mital R, Otto TS, Savu A, Baumrin E, Cardones AR, Carlesimo M, Caro G, Freites-Martinez A, Hirner JP, Markova A, McLellan BN, Rossi A, Sauder MB, Seminario-Vidal L, Sibaud V, Owen DH, Dulmage BO, Chen ST, Kaffenberger BH Detection of novel therapies using a multi-national, multi-institutional registry of cutaneous immune-related adverse events and management , Int J Dermatol, 62(8): 2023,1020-1025

Baumrin E, Baker LX, Byrne M, Martin PJ, Flowers ME, Onstad L, El Jurdi N, Chen H, Beeghly-Fadiel A, Lee SJ, Tkaczyk ER Prognostic Value of Cutaneous Disease Severity Estimates on Survival Outcomes in Patients With Chronic Graft-vs-Host Disease , JAMA Dermatol, 159(4): 2023,393-402

Willer QA, Bowers JT, Baumrin E, Lipoff JB Establishment of a dermatology clinic serving both patients living with HIV/AIDS and transgender individuals (PRIDE clinic) in an urban academic setting: Demographics, evolution, and lessons learned , J Am Acad Dermatol, 88(4): 2022,882-885

View all publications